Back to Browse Journals » Vascular Health and Risk Management » Volume 4 » Issue 5

Habitual coffee consumption and blood pressure: An epidemiological perspective

Authors Johanna M Geleijnse

Published 10 October 2008 Volume 2008:4(5) Pages 963—970

DOI http://dx.doi.org/10.2147/VHRM.S3055

Review by Single-blind

Peer reviewer comments 3

Johanna M Geleijnse

Division of Human Nutrition, Wageningen University, The Netherlands

Abstract: This paper summarizes the current epidemiological evidence on coffee consumption in relation to blood pressure (BP) and risk of hypertension. Data from crosssectional studies suggest an inverse linear or U-shaped association of habitual coffee use with BP in different populations. Prospective studies suggest a protective effect of high coffee intake (4 or more cups per day) against hypertension, mainly in women. Furthermore, the risk of hypertension may be lower in coffee abstainers. Randomized controlled trials, which are mostly of short duration (1–12 weeks), have shown that coffee intake around 5 cups per day causes a small elevation in BP (∼2/1 mmHg) when compared to abstinence or use of decaffeinated coffee. With regard to underlying biological mechanisms, most research has been devoted to BP-raising effects of caffeine. However, there are many other substances in coffee, such as polyphenols, soluble fi bre and potassium, which could exert a beneficial effect in the cardiovascular system. Although the precise nature of the relation between coffee and BP is still unclear, most evidence suggests that regular intake of caffeinated coffee does not increase the risk of hypertension.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Readers of this article also read:

Clinical deterioration after sildenafil cessation in patients with pulmonary hypertension

Anne M Keogh, Andrew Jabbour, Christopher S Hayward, Peter S Macdonald

Vascular Health and Risk Management 2008, 4:1111-1113

Published Date: 10 October 2008

Under- and overreporting of energy in a group of candidates for CABG surgery and its association with some anthropometric and sociodemographic factors, Tehran, Iran

Bahareh Amirkalali, Mehdi Najafi, Asal Ataie-Jafari, Saeed Hosseini, Ramin Heshmat

Vascular Health and Risk Management 2008, 4:1115-1120

Published Date: 10 October 2008

Subtemporal approach to basilar tip aneurysm with division of posterior communicating artery: Technical note

Shunsuke Kakino, Kuniaki Ogasawara, Yoshitaka Kubo, Hideaki Nishimoto, Akira Ogawa

Vascular Health and Risk Management 2008, 4:931-935

Published Date: 8 August 2008

Relationship between serum albumin and pulse wave velocity in patients on continuous ambulatory peritoneal dialysis

Li-Tao Cheng, Li-Jun Tang, Hui-Min Chen, Wen Tang, Tao Wang

Vascular Health and Risk Management 2008, 4:871-876

Published Date: 8 August 2008

Systematic review of implementation strategies for risk tables in the prevention of cardiovascular diseases

Ben van Steenkiste, Richard Grol, Trudy van der Weijden

Vascular Health and Risk Management 2008, 4:535-545

Published Date: 6 June 2008

Perioperative hypertension management

Joseph Varon, Paul E Marik

Vascular Health and Risk Management 2008, 4:615-627

Published Date: 6 June 2008

Methodological issues in cardiovascular epidemiology: the risk of determining absolute risk through statistical models

Demosthenes B Panagiotakos, Vassilis Stavrinos

Vascular Health and Risk Management 2006, 2:309-315

Published Date: 15 September 2006